Age Distribution of Multiple Functionally Relevant Subsets of CD4+ T Cells in Human Blood Using a Standardized and Validated 14-Color EuroFlow Immune Monitoring Tube.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 02 09 2019
accepted: 21 01 2020
entrez: 17 3 2020
pubmed: 17 3 2020
medline: 9 3 2021
Statut: epublish

Résumé

CD4+ T cells comprise multiple functionally distinct cell populations that play a key role in immunity. Despite blood monitoring of CD4+ T-cell subsets is of potential clinical utility, no standardized and validated approaches have been proposed so far. The aim of this study was to design and validate a single 14-color antibody combination for sensitive and reproducible flow cytometry monitoring of CD4+ T-cell populations in human blood to establish normal age-related reference values and evaluate the presence of potentially altered profiles in three distinct disease models-monoclonal B-cell lymphocytosis (MBL), systemic mastocytosis (SM), and common variable immunodeficiency (CVID). Overall, 145 blood samples from healthy donors were used to design and validate a 14-color antibody combination based on extensive reagent testing in multiple cycles of design-testing-evaluation-redesign, combined with

Identifiants

pubmed: 32174910
doi: 10.3389/fimmu.2020.00166
pmc: PMC7056740
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

166

Informations de copyright

Copyright © 2020 Botafogo, Pérez-Andres, Jara-Acevedo, Bárcena, Grigore, Hernández-Delgado, Damasceno, Comans, Blanco, Romero, Arriba-Méndez, Gastaca-Abasolo, Pedreira, van Gaans-van den Brink, Corbiere, Mascart, van Els, Barkoff, Mayado, van Dongen, Almeida and Orfao.

Références

Cytometry A. 2019 Jun;95(6):647-654
pubmed: 30714682
Immunity. 2011 Jan 28;34(1):108-21
pubmed: 21215658
Nat Immunol. 2009 Aug;10(8):857-63
pubmed: 19578369
Clin Immunol. 2009 Jan;130(1):27-33
pubmed: 18845487
J Immunol. 2008 May 15;180(10):6713-24
pubmed: 18453591
Nat Protoc. 2019 Jul;14(7):1946-1969
pubmed: 31160786
PLoS One. 2015 Sep 14;10(9):e0138042
pubmed: 26367374
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7916-21
pubmed: 15905333
J Immunol. 2018 Jan 1;200(1):336-346
pubmed: 29180490
Sci Rep. 2016 Feb 10;6:20686
pubmed: 26861911
Front Oncol. 2019 Oct 04;9:1002
pubmed: 31637216
Semin Immunol. 2013 Nov 15;25(4):252-62
pubmed: 24183700
Biomed Res Int. 2015;2015:521957
pubmed: 26583116
Alcohol Clin Exp Res. 2013 Aug;37(8):1361-9
pubmed: 23550693
Transplant Res. 2013 Oct 25;2(1):17
pubmed: 24160259
Methods Mol Biol. 2018;1745:67-82
pubmed: 29476463
J Allergy Clin Immunol. 2018 Jun;141(6):2048-2060.e13
pubmed: 28939412
Cytometry A. 2015 Apr;87(4):289-92
pubmed: 25407958
PLoS One. 2016 Feb 10;11(2):e0148260
pubmed: 26863434
Br J Haematol. 2017 Jul;178(2):257-266
pubmed: 28419441
J Allergy Clin Immunol. 2018 Jun;141(6):2208-2219.e16
pubmed: 29505809
Nature. 1999 Oct 14;401(6754):708-12
pubmed: 10537110
J Immunol. 2011 May 15;186(10):5556-68
pubmed: 21471443
J Clin Immunol. 2013 Aug;33(6):1126-33
pubmed: 23793781
Nat Immunol. 2019 Mar;20(3):301-312
pubmed: 30664737
J Immunol Methods. 2019 Dec;475:112631
pubmed: 31306640
Clin Exp Allergy. 2008 Dec;38(12):1847-57
pubmed: 19037961
Int Rev Cell Mol Biol. 2018;341:63-124
pubmed: 30262035
Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7225-30
pubmed: 26015572
J Exp Med. 1987 Nov 1;166(5):1229-44
pubmed: 2960769
Leukemia. 2017 Oct;31(10):2094-2103
pubmed: 28104919
Front Immunol. 2019 Mar 04;10:246
pubmed: 30886612
J Immunol. 2012 Apr 15;188(8):3734-44
pubmed: 22427637
Front Immunol. 2014 May 14;5:217
pubmed: 24860576
Leukemia. 2010 Nov;24(11):1927-33
pubmed: 20844562
J Immunol. 1986 Apr 1;136(7):2348-57
pubmed: 2419430
Nat Rev Immunol. 2008 Apr;8(4):247-58
pubmed: 18323851
Lab Invest. 2004 Oct;84(10):1387-98
pubmed: 15311213
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4793-8
pubmed: 19273860
Leukemia. 2012 Sep;26(9):1986-2010
pubmed: 22948490
Cytometry A. 2008 Nov;73(11):975-83
pubmed: 18785267
Vaccine. 2013 Dec 17;32(1):111-8
pubmed: 24176499
J Viral Hepat. 2011 Jul;18(7):e341-9
pubmed: 21692946
Front Immunol. 2019 May 09;10:940
pubmed: 31143175
Annu Rev Immunol. 2003;21:425-56
pubmed: 12615888
Immunology. 2019 May;157(1):3-12
pubmed: 30897205
Eur J Immunol. 2017 Apr;47(4):607-614
pubmed: 28295238
Eur J Immunol. 2012 Sep;42(9):2215-20
pubmed: 22949319
Blood. 2009 Jan 22;113(4):769-74
pubmed: 18583570
Cytometry A. 2015 Dec;87(12):1067-9
pubmed: 26506224
Blood. 2007 May 15;109(10):4343-50
pubmed: 17234745
Am J Transplant. 2010 Nov;10(11):2410-20
pubmed: 20977632
Nat Med. 2011 Sep 18;17(10):1290-7
pubmed: 21926977
Cytometry B Clin Cytom. 2013 Jan-Feb;84(1):50-4
pubmed: 23019018
Front Immunol. 2019 May 16;10:1034
pubmed: 31156625
Cell Rep. 2015 Jun 23;11(11):1822-33
pubmed: 26074076
Eur J Immunol. 2013 Nov;43(11):2797-809
pubmed: 24258910
Lancet Infect Dis. 2019 May;19(5):e179-e186
pubmed: 30503084
Cytometry A. 2013 May;83(5):439-40
pubmed: 23450796
Immunity. 2016 May 17;44(5):1227-39
pubmed: 27178470
Cell. 2015 Apr 9;161(2):387-403
pubmed: 25772697
BMC Genomics. 2019 Jul 11;20(1):571
pubmed: 31296163
J Immunol Methods. 2019 Dec;475:112618
pubmed: 31181212
Cytometry A. 2014 Jan;85(1):25-35
pubmed: 24124072
Blood. 2012 May 10;119(19):4430-40
pubmed: 22438251
Ann N Y Acad Sci. 2013 May;1284:66-70
pubmed: 23651196
J Allergy Clin Immunol. 2018 Sep;142(3):970-973.e8
pubmed: 29746882
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419
J Clin Invest. 2009 Dec;119(12):3573-85
pubmed: 19920355

Auteurs

Vitor Botafogo (V)

Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.
Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.
Clinical Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Martín Pérez-Andres (M)

Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.
Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.

María Jara-Acevedo (M)

Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.
Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.
Sequencing Service, NUCLEUS, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

Paloma Bárcena (P)

Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.
Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.

Georgiana Grigore (G)

Cytognos SL, Salamanca, Spain.

Alejandro Hernández-Delgado (A)

Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.
Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.
Cytognos SL, Salamanca, Spain.

Daniela Damasceno (D)

Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.
Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.

Suzanne Comans (S)

Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, Netherlands.

Elena Blanco (E)

Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.
Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.

Alfonso Romero (A)

Miguel Armijo Primary Health Care Centre, Sanidad de Castilla y León (SACYL), Salamanca, Spain.

Sonia Arriba-Méndez (S)

Pediatrics Service, University Hospital of Salamanca, Salamanca, Spain.

Irene Gastaca-Abasolo (I)

Gynecology and Obstetrics Service, University Hospital of Salamanca, Salamanca, Spain.

Carlos Eduardo Pedreira (CE)

Systems and Computing Department (PESC), COPPE, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.

Jacqueline A M van Gaans-van den Brink (JAM)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Véronique Corbiere (V)

Laboratory of Vaccinology and Mucosal Immunity, Université libre de Bruxelles (ULB), Brussels, Belgium.

Françoise Mascart (F)

Laboratory of Vaccinology and Mucosal Immunity, Université libre de Bruxelles (ULB), Brussels, Belgium.
Immunobiology Clinic, Hôpital Erasme, Brussels, Belgium.

Cécile A C M van Els (CACM)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Alex-Mikael Barkoff (AM)

Institute of Biomedicine, Department of Microbiology, Virology and Immunology, University of Turku (UTU), Turku, Finland.

Andrea Mayado (A)

Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.
Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.

Jacques J M van Dongen (JJM)

Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, Netherlands.

Julia Almeida (J)

Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.
Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.

Alberto Orfao (A)

Translational and Clinical Research Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cancer (IBMCC), CSIC-University of Salamanca (USAL), Salamanca, Spain.
Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH